Literature DB >> 7789752

Vicious circles: looking back on resistance plasmids.

J Davies1.   

Abstract

Mesh：

Year:  1995        PMID： 7789752      PMCID： PMC1206476     

Source DB:  PubMed          Journal:  Genetics        ISSN： 0016-6731            Impact factor:   4.562


× No keyword cloud information.
  10 in total

Review 1.  Origins and evolution of antibiotic resistance.

Authors:  Julian Davies; Dorothy Davies
Journal:  Microbiol Mol Biol Rev       Date:  2010-09       Impact factor: 11.056

2.  Microbes have the last word. A drastic re-evaluation of antimicrobial treatment is needed to overcome the threat of antibiotic-resistant bacteria.

Authors:  Julian Davies
Journal:  EMBO Rep       Date:  2007-07       Impact factor: 8.807

Review 3.  The Whys and Wherefores of Antibiotic Resistance.

Authors:  Cameron R Strachan; Julian Davies
Journal:  Cold Spring Harb Perspect Med       Date:  2017-02-01       Impact factor: 6.915

Review 4.  Lateral gene transfer between prokaryotes and eukaryotes.

Authors:  Karsten B Sieber; Robin E Bromley; Julie C Dunning Hotopp
Journal:  Exp Cell Res       Date:  2017-02-09       Impact factor: 3.905

5.  Natural microbial communities supporting the transfer of the IncP-1β plasmid pB10 exhibit a higher initial content of plasmids from the same incompatibility group.

Authors:  Xavier Bellanger; Hélène Guilloteau; Bérengère Breuil; Christophe Merlin
Journal:  Front Microbiol       Date:  2014-11-24       Impact factor: 5.640

6.  Comparing optimization criteria in antibiotic allocation protocols.

Authors:  Alastair Jamieson-Lane; Alexander Friedrich; Bernd Blasius
Journal:  R Soc Open Sci       Date:  2022-03-23       Impact factor: 2.963

Review 7.  Bacterial Responses and Genome Instability Induced by Subinhibitory Concentrations of Antibiotics.

Authors:  Luisa Laureti; Ivan Matic; Arnaud Gutierrez
Journal:  Antibiotics (Basel)       Date:  2013-03-14

Review 8.  The importance of integrons for development and propagation of resistance in Shigella: the case of Latin America.

Authors:  Kenia Barrantes; Rosario Achí
Journal:  Braz J Microbiol       Date:  2016-07-26       Impact factor: 2.476

9.  Epidemiology and risk factors for multidrug-resistant bacteria in critically ill patients with liver disease.

Authors:  Anirban Hom Choudhuri; Priyanka Khurana; Partha Sarathi Biswas; Rajeev Uppal
Journal:  Saudi J Anaesth       Date:  2018 Jul-Sep

Review 10.  Biogenic Nanosilver against Multidrug-Resistant Bacteria (MDRB).

Authors:  Caio H N Barros; Stephanie Fulaz; Danijela Stanisic; Ljubica Tasic
Journal:  Antibiotics (Basel)       Date:  2018-08-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.